Profilo
Christopher Brinsmead is currently Chairman at Proveca Ltd. since 2013, Director at Cdb Meadowside Ltd., Council Member at Imperial College London, and Partner at EOS Syndicate Management Ltd. since 2020.
Former roles include Chairman-Designate at Consort Medical Ltd. in 2019, Chairman-Europe Division at Proteus Digital Health, Inc. from 2011 to 2014, Non-Executive Chairman at Scapa Group Ltd. from 2020 to 2021, Chairman & President at AstraZeneca UK Ltd. from 1980 to 2010, Chairman at Bamburgh Capital Ltd. and PeakData AG, Non-Executive Director at UDG Healthcare Ltd. (Dublin) from 2019 to 2020, Non-Executive Director at Domino Printing Sciences Plc from 2008 to 2012, Director at Wesleyan Assurance Society from 2010 to 2019, Senior Independent Director at Cambian Group Ltd. from 2014 to 2017, President & Director at The Association of the British Pharmaceutical Industry from 2008 to 2010, Director at Datapharm Communications Ltd., Non-Executive Director at Kinapse Ltd. from 2010 to 2016, Non-Executive Director at Collagen Solutions (US) LLC from 2018 to 2019, Non-Executive Director at Optibiotix Health Plc from 2021 to 2023, and President at Astrazeneca UK Ltd. (Ireland).
Education includes undergraduate studies at The University of Nottingham and graduate studies at Manchester Business School.
Posizioni attive di Chris Brinsmead
| Società | Posizione | Inizio |
|---|---|---|
Proveca Ltd.
Proveca Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for children and adults | Presidente | 01/01/2013 |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cdb Meadowside Ltd. | Direttore/Membro del Consiglio | - |
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Investitore di Private Equity | 01/03/2020 |
Precedenti posizioni note di Chris Brinsmead
| Società | Posizione | Fine |
|---|---|---|
| OPTIBIOTIX HEALTH PLC | Direttore/Membro del Consiglio | 26/07/2023 |
| SCAPA GROUP | Presidente | 15/04/2021 |
| UDG HEALTHCARE PLC | Direttore/Membro del Consiglio | 28/01/2020 |
Wesleyan Assurance Society
Wesleyan Assurance Society Investment ManagersFinance Wesleyan is an active, long-term, risk-averse manager which generally follows a buy and hold approach to invest across asset classes. They believe income is an important component of investment return and that real asset growth in income will ultimately lead to capital appreciation. The firm is typically a contra-cyclical investor which aim to identify long-term value in sectors and stocks which are temporarily out of favor with other investors. | Direttore/Membro del Consiglio | 01/01/2019 |
| CAMBIAN GROUP PLC | Direttore/Membro del Consiglio | 05/06/2017 |
Formazione di Chris Brinsmead
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 22 |
|---|---|
Consort Medical Ltd.
Consort Medical Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Health Technology |
UDG Healthcare Ltd. (Dublin)
UDG Healthcare Ltd. (Dublin) Miscellaneous Commercial ServicesCommercial Services Provides healthcare advisory, communications, commercial, clinical and packaging services | Commercial Services |
Domino Printing Sciences Plc
Domino Printing Sciences Plc Industrial MachineryProducer Manufacturing Develops, manufactures and sells ink jet printing systems & related consumables | Producer Manufacturing |
Scapa Group Ltd.
Scapa Group Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Wesleyan Assurance Society
Wesleyan Assurance Society Investment ManagersFinance Wesleyan is an active, long-term, risk-averse manager which generally follows a buy and hold approach to invest across asset classes. They believe income is an important component of investment return and that real asset growth in income will ultimately lead to capital appreciation. The firm is typically a contra-cyclical investor which aim to identify long-term value in sectors and stocks which are temporarily out of favor with other investors. | Finance |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Cambian Group Ltd.
Cambian Group Ltd. Medical/Nursing ServicesHealth Services Provides specialist services in education, mental health rehabilitation and learning disabilities | Health Services |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Commercial Services |
Manchester Business School
Manchester Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Datapharm Communications Ltd. | |
Astrazeneca UK Ltd. (Ireland)
Astrazeneca UK Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company it develops medicines | Health Technology |
Kinapse Ltd.
Kinapse Ltd. Miscellaneous Commercial ServicesCommercial Services Provides consulting and outsourcing services to the life sciences industry | Commercial Services |
Bamburgh Capital Ltd.
Bamburgh Capital Ltd. Investment ManagersFinance Provides financial management services | Finance |
Proveca Ltd.
Proveca Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for children and adults | Health Technology |
Collagen Solutions (US) LLC
Collagen Solutions (US) LLC BiotechnologyHealth Technology Engages in development, manufacturing and supply of medical grade collagen components & biomaterials | Health Technology |
Optibiotix Health Plc
Optibiotix Health Plc BiotechnologyHealth Technology Develops biological products for digestive health | Health Technology |
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Finance |
Cdb Meadowside Ltd. | |
PeakData AG
PeakData AG Information Technology ServicesTechnology Services Operates as a software platform to identify and analyze for therapeutic | Technology Services |
















